Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-02-22
1996-06-25
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A01N 4500
Patent
active
055299911
ABSTRACT:
This invention relates to delayed and sustained release oral medicaments and, more specifically, to delayed and sustained release activated vitamin D, oral medicament.
REFERENCES:
patent: 2216719 (1940-10-01), Boer
patent: 2434015 (1948-01-01), Rosenberg et al.
patent: 4230701 (1980-10-01), Holick et al.
patent: 4335120 (1982-06-01), Holick et al.
patent: 4505906 (1985-03-01), DeLuca et al.
patent: 4539153 (1985-09-01), Vandewalle et al.
patent: 4684524 (1987-08-01), Echenhoff et al.
patent: 4728643 (1988-03-01), Holick et al.
patent: 5013728 (1991-05-01), Grodberg
CA 116:254522 1991.
CA 115:278633 1990.
CA 110:107718 1988.
CA 116:75862 1991.
Patent Abstracts of Japan, vol. 8, No. 93 (C-220) (1530) 27 Apr. 1984 document member of JP patent family JP,A, 59 010562 (TEIJIN K.K.) 20 Jan. 1984. (English Abstract only.).
Transactions of the Association of American Physicians, vol. XCII, 1979, pp. 54-63, M. F. Holick, S. C. McNeill, J. A. MacLaughlin, S. A. Holick, M. B. Clark and J. T. Potts, Jr., "Physiologic Implications of the Formation of Previtamin D in Skin".
Chemical Abstracts, vol. 110, No. 10, 1989, Columbus, Ohio, Abstract No. 84136v, M. Takahashi, H. Mochizuki, "Enteric-Soluble Capsule Base Composed of Poly(Ethylene Glycol) or Its Substitutes and Cellulose Acetate Phthalate or Hydroxypropyl Methyl Cellulose Phthalate".
Harrison's Principles of Internal Medicine: Part Eleven, "Disorders of Bone & Mineral Metabolism," Chapter 335, E. Brauwald et al., (eds.) McGraw-Hill, New York (1987) pp. 1860-1865.
M. L. Curtin and W. H. Okamura, J. Am. Chem. Soc., vol. 113 (1991) pp. 6958-6966.
Bishop Charles W.
Knutson Joyce C.
Valliere Charles R.
Killos Paul J.
Lunar Corporation
Welch Teresa J.
LandOfFree
Oral 1.alpha.-hydroxyprevitamin D does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral 1.alpha.-hydroxyprevitamin D, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral 1.alpha.-hydroxyprevitamin D will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2188932